ADHD continues to occur at epidemic levels in our society.  Thirty-five years ago, only a handful of children and teens were considered to have what at the time was called ‘’hyperkinesis’’ or ‘’minimal brain dysfunction.’’ Now, the diagnosis takes in almost 10% of all children and teens.  Most of these kids (62%) are taking ADHD...Read More

I read an online article today from Benzinga, a financial media company that empowers its readers with daily actionable market analysis and commentary.  It reported on a new ADHD drug that the FDA had just approved, called Cotempla XR-OTD, a methylphenidate extended release orally-disintegrating tablet for treating ADHD in kids aged 6-17.  According to BMO...Read More

A new study of Scottish children published in the JAMA Pediatrics this week, suggests that the 1.0% of subjects (N= 7413) that were being medicated for attention deficit hyperactivity disorder had poorer outcomes on a wide range of measures compared with others in the study (N=766,244). The outcomes included: poor academic attainment, unauthorized absence from...Read More

I’ve been concerned about the lack of input that children and adolescents diagnosed with ADHD have relating to their diagnosis and treatment.  Now a new study in the May 2017 issue of the Community Mental Health Journal reports that children with a diagnosis of ADHD want to talk with their doctors about their diagnosis and the...Read More

A study in The Journal of Child Psychology and Psychiatry last month reported that”extended use of medication [for ADHD] was associated with suppression of adult height but not with reduction of symptom severity.” So basically, it stunts growth and it isn’t effective. So why isn’t there a bigger hue and cry about this? There are...Read More